CLINICAL_TRIALS trial_result · 2009-06-24

Clinical Trial Update: A Study to Investigate the Antihypertensive Efficacy of MK0954 [Phase 3]

A Phase 3 trial evaluating the antihypertensive efficacy of MK0954 by Merck Sharp & Dohme LLC has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-06-24